ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3–targeting antibody-drug conjugate, in patients with advanced solid tumor.

Wang, Jie, Duan, Jianchun, Xing, Ligang · Journal of Clinical Oncology · 2023